
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Publication
, Journal Article
Levine, GN; Bates, ER; Bittl, JA; Brindis, RG; Fihn, SD; Fleisher, LA; Granger, CB; Lange, RA; Mack, MJ; Mauri, L; Mehran, R; Mukherjee, D ...
Published in: J Thorac Cardiovasc Surg
November 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Thorac Cardiovasc Surg
DOI
EISSN
1097-685X
Publication Date
November 2016
Volume
152
Issue
5
Start / End Page
1243 / 1275
Location
United States
Related Subject Headings
- United States
- Respiratory System
- Platelet Aggregation Inhibitors
- Humans
- Drug-Eluting Stents
- Coronary Artery Disease
- American Heart Association
- Algorithms
- Advisory Committees
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., … Wijeysundera, D. N. (2016). 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg, 152(5), 1243–1275. https://doi.org/10.1016/j.jtcvs.2016.07.044
Levine, Glenn N., Eric R. Bates, John A. Bittl, Ralph G. Brindis, Stephan D. Fihn, Lee A. Fleisher, Christopher B. Granger, et al. “2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.” J Thorac Cardiovasc Surg 152, no. 5 (November 2016): 1243–75. https://doi.org/10.1016/j.jtcvs.2016.07.044.
Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016 Nov;152(5):1243–75.
Levine, Glenn N., et al. “2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.” J Thorac Cardiovasc Surg, vol. 152, no. 5, Nov. 2016, pp. 1243–75. Pubmed, doi:10.1016/j.jtcvs.2016.07.044.
Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O’Gara PT, Sabatine MS, Smith PK, Smith SC, Halperin JL, Al-Khatib SM, Birtcher KK, Bozkurt B, Cigarroa JE, Curtis LH, Gentile F, Gidding S, Hlatky MA, Ikonomidis JS, Joglar JA, Pressler SJ, Wijeysundera DN. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016 Nov;152(5):1243–1275.

Published In
J Thorac Cardiovasc Surg
DOI
EISSN
1097-685X
Publication Date
November 2016
Volume
152
Issue
5
Start / End Page
1243 / 1275
Location
United States
Related Subject Headings
- United States
- Respiratory System
- Platelet Aggregation Inhibitors
- Humans
- Drug-Eluting Stents
- Coronary Artery Disease
- American Heart Association
- Algorithms
- Advisory Committees
- 3202 Clinical sciences